Pricing Log in Create free account

Anika Therapeutics Inc. (ANIK) vs Alpha Teknova, Inc. (TKNO)

Anika Therapeutics Inc. and Alpha Teknova, Inc. are both Drug Manufacturers Specialty & Generic companies. Alpha Teknova, Inc. is the larger, with a market value of $408.0M against $276.9M — 1.5× the size. Alpha Teknova, Inc. grew revenue faster over the last twelve months: 12.3% against 5.33%. Anika Therapeutics Inc. has the higher net margin (−3.14% vs −38.4%) and the higher return on invested capital (−3.24% vs −16.9%). Across the 18 metrics below, Anika Therapeutics Inc. leads on 14 and Alpha Teknova, Inc. on 4.

Valuation

Metric ANIK TKNO Drug Manufacturers Specialty & Generic median
P/E n/m n/m 19.25
P/S 2.21 8.69 2.11
P/B 1.94 6.07 1.78
Price to free cash flow 473.90 n/m 16.14
EV/EBITDA 493.99 n/m 12.58
EV/Sales 2.10 8.69 2.73
Earnings yield (1.30%) (4.38%) (4.38%)
Free cash flow yield 0.21% (1.94%) 0.00%

Profitability

Metric ANIK TKNO Drug Manufacturers Specialty & Generic median
Gross margin 62.16% 34.60% 53.94%
Operating margin (4.24%) (36.19%) 0.00%
Net margin (3.14%) (38.37%) 0.00%
Free cash flow margin 0.47% (16.83%) 0.00%
Return on equity (2.66%) (24.19%) (0.40%)
Return on assets (2.04%) (16.25%) (3.32%)
Return on invested capital (3.24%) (16.93%) 0.00%

Growth

Metric ANIK TKNO Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) 5.33% 12.27% 10.01%
EPS growth (last fiscal year) 80.16% 43.86% 49.06%
Revenue growth, 5-year CAGR (2.86%) 5.30% 6.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ANIK TKNO Drug Manufacturers Specialty & Generic median
Debt to equity 0.00 0.21 0.05
Current ratio 4.48 4.49 2.31
Net debt to EBITDA 10.80 0.75 0.97

Dividend

Metric ANIK TKNO Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.57%
Payout ratio — — 0.27

Size

Metric ANIK TKNO Drug Manufacturers Specialty & Generic median
Market cap 276.90m 408.03m 276.90m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack